Suscripción a Biblioteca: Guest

Reinvigorating Exhausted T Cells by Blockade of the PD-1 Pathway

Volumen 6, Edición 1-2, 2015, pp. 7-17
DOI: 10.1615/ForumImmunDisTher.2015014188
Get accessGet access

SINOPSIS

T-cell exhaustion due to persistent antigen stimulation is a key feature of chronic viral infections and cancer. Programmed cell death-1 (PD-1) is a major regulator of T-cell exhaustion, and blocking the PD-1 pathway restores T-cell function and improves pathogen control and tumor eradication. Immunotherapy targeting the PD-1 inhibitory receptor pathway has demonstrated significant antitumor activity. Recently, antibodies blocking PD-1 have been approved for use in cancer patients. In this review, we summarize the role of the PD-1 pathway in chronic infection and cancer and the therapeutic potential of PD-1-directed immunotherapy in patients with chronic infection or cancer.

CITADO POR
  1. Kersh Anna E., Ng Spencer, Chang Yun Min, Sasaki Maiko, Thomas Susan N., Kissick Haydn T., Lesinski Gregory B., Kudchadkar Ragini R., Waller Edmund K., Pollack Brian P., Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer, The Journal of Clinical Pharmacology, 58, 1, 2018. Crossref

  2. Shindiapina Polina, Alinari Lapo, Pembrolizumab and its role in relapsed/refractory classical Hodgkin’s lymphoma: evidence to date and clinical utility, Therapeutic Advances in Hematology, 9, 4, 2018. Crossref

  3. Fonseca Raíssa, Salgado Rafael Moysés, Borges da Silva Henrique, Nascimento Rogério Silva do, D’Império-Lima Maria Regina, Alvarez José Maria, Programmed Cell Death Protein 1–PDL1 Interaction Prevents Heart Damage in Chronic Trypanosoma cruzi Infection, Frontiers in Immunology, 9, 2018. Crossref

  4. De Sousa Linhares Annika, Leitner Judith, Grabmeier-Pfistershammer Katharina, Steinberger Peter, Not All Immune Checkpoints Are Created Equal, Frontiers in Immunology, 9, 2018. Crossref

  5. Czaja Albert J., Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management, Digestive Diseases and Sciences, 63, 7, 2018. Crossref

  6. Chin S. Michael, Kimberlin Christopher R., Roe-Zurz Zygy, Zhang Pamela, Xu Allison, Liao-Chan Sindy, Sen Debasish, Nager Andrew R., Oakdale Nicole Schirle, Brown Colleen, Wang Feng, Yang Yuting, Lindquist Kevin, Yeung Yik Andy, Salek-Ardakani Shahram, Chaparro-Riggers Javier, Structure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab, Nature Communications, 9, 1, 2018. Crossref

  7. Walkowska Joanna, Kallemose Thomas, Jönsson Göran, Jönsson Mats, Andersen Ove, Andersen Mads Hald, Svane Inge Marie, Langkilde Anne, Nilbert Mef, Therkildsen Christina, Immunoprofiles of colorectal cancer from Lynch syndrome, OncoImmunology, 8, 1, 2019. Crossref

  8. Siozopoulou Vasiliki, Marcq Elly, Jacobs Julie, Zwaenepoel Karen, Hermans Christophe, Brauns Jantine, Pauwels Siegrid, Huysentruyt Clément, Lammens Martin, Somville Johan, Smits Evelien, Pauwels Patrick, Desmoid tumors display a strong immune infiltration at the tumor margins and no PD-L1-driven immune suppression, Cancer Immunology, Immunotherapy, 68, 10, 2019. Crossref

  9. Morris Gerwyn, Maes Michael, Berk Michael, Puri Basant K., Myalgic encephalomyelitis or chronic fatigue syndrome: how could the illness develop?, Metabolic Brain Disease, 34, 2, 2019. Crossref

  10. Slutsky Rebecca, Romero Roberto, Xu Yi, Galaz Jose, Miller Derek, Done Bogdan, Tarca Adi L., Gregor Sabrina, Hassan Sonia S., Leng Yaozhu, Gomez-Lopez Nardhy, Exhausted and Senescent T Cells at the Maternal-Fetal Interface in Preterm and Term Labor, Journal of Immunology Research, 2019, 2019. Crossref

  11. Verma Vivek, Shrimali Rajeev K, Ahmad Shamim, Dai Winjie, Wang Hua, Lu Sumin, Nandre Rahul, Gaur Pankaj, Lopez Jose, Sade-Feldman Moshe, Yizhak Keren, Bjorgaard Stacey L., Flaherty Keith T., Wargo Jennifer A., Boland Genevieve M., Sullivan Ryan J., Getz Gad, Hammond Scott A., Tan Ming, Qi Jingjing, Wong Phillip, Merghoub Taha, Wolchok Jedd, Hacohen Nir, Janik John E., Mkrtichyan Mikayel, Gupta Seema, Khleif Samir N., PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance, Nature Immunology, 20, 9, 2019. Crossref

  12. Li Matthew, Chin Ling-Yee, Shukor Sykuri, Tamayo Alfred G., Maus Marcela V., Parekkadan Biju, Effects of intermittent T-cell cluster disaggregation on proliferative capacity and checkpoint marker expression, Autoimmunity, 52, 3, 2019. Crossref

  13. Pieren Daan K. J., Smits Noortje A. M., van de Garde Martijn D. B., Guichelaar Teun, Response kinetics reveal novel features of ageing in murine T cells, Scientific Reports, 9, 1, 2019. Crossref

  14. Hope Jennifer L., Stairiker Christopher J., Bae Eun-Ah, Otero Dennis C., Bradley Linda M., Striking a Balance—Cellular and Molecular Drivers of Memory T Cell Development and Responses to Chronic Stimulation, Frontiers in Immunology, 10, 2019. Crossref

  15. Cho Yong-Hee, Choi Myeong Geun, Kim Dong Ha, Choi Yun Jung, Kim Seon Ye, Sung Ki Jung, Lee Jae Cheol, Kim Sang-Yeob, Rho Jin Kyung, Choi Chang-Min, Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer, Targeted Oncology, 15, 2, 2020. Crossref

  16. Mirabile Aurora, Rivoltini Licia, Daveri Elena, Vernieri Claudio, Mele Roberto, Porcu Luca, Lazzari Chiara, Bulotta Alessandra, Viganò Maria Grazia, Cascinu Stefano, Gregorc Vanesa, Metabolism and Immune Modulation in Patients with Solid Tumors: Systematic Review of Preclinical and Clinical Evidence, Cancers, 12, 5, 2020. Crossref

  17. Holmes Mikaela, Mahar Annabelle, Lum Trina, Kao Steven, Cooper Wendy Anne, Real-world programmed death-ligand 1 prevalence rates in non-small cell lung cancer: correlation with clinicopathological features and tumour mutation status, Journal of Clinical Pathology, 74, 2, 2021. Crossref

  18. Dumauthioz Nina, Tschumi Benjamin, Wenes Mathias, Marti Bastien, Wang Haiping, Franco Fabien, Li Wenhui, Lopez-Mejia Isabel C., Fajas Lluis, Ho Ping-Chih, Donda Alena, Romero Pedro, Zhang Lianjun, Enforced PGC-1α expression promotes CD8 T cell fitness, memory formation and antitumor immunity, Cellular & Molecular Immunology, 18, 7, 2021. Crossref

  19. Enyindah-Asonye Gospel, Nwankwo Anthony, Rahman Mohammad Arif, Hunegnaw Ruth, Hogge Christopher, Helmold Hait Sabrina, Ko Eun-Ju, Hoang Tanya, Robert-Guroff Marjorie, Overexpression of CD6 and PD-1 Identifies Dysfunctional CD8+ T-Cells During Chronic SIV Infection of Rhesus Macaques, Frontiers in Immunology, 10, 2020. Crossref

  20. Jafari Sevda, Molavi Ommoleila, Kahroba Houman, Hejazi Mohammad Saied, Maleki-Dizaji Nasrin, Barghi Siamak, Kiaie Seyed Hossein, Jadidi-Niaragh Farhad, Clinical application of immune checkpoints in targeted immunotherapy of prostate cancer, Cellular and Molecular Life Sciences, 77, 19, 2020. Crossref

  21. Kang Mikyung, Hong Jihye, Jung Mungyo, Kwon Sung Pil, Song Seuk Young, Kim Han Young, Lee Ju‐Ro, Kang Seokyung, Han Jin, Koo Ja‐Hyun, Ryu Ju Hee, Lim Songhyun, Sohn Hee Su, Choi Je‐Min, Doh Junsang, Kim Byung‐Soo, T‐Cell‐Mimicking Nanoparticles for Cancer Immunotherapy, Advanced Materials, 32, 39, 2020. Crossref

  22. Wang Shu‐Hung, Zissler Ulrich M., Buettner Maren, Heine Sonja, Heldner Alexander, Kotz Sebastian, Pechtold Lisa, Kau Josephine, Plaschke Mirjam, Ullmann Julia T., Guerth Ferdinand, Oelsner Madlen, Alessandrini Francesca, Blank Simon, Chaker Adam M., Schmidt‐Weber Carsten B., Jakwerth Constanze A., An exhausted phenotype of T H 2 cells is primed by allergen exposure, but not reinforced by allergen‐specific immunotherapy , Allergy, 76, 9, 2021. Crossref

  23. Nyambuya Tawanda Maurice, Dludla Phiwayinkosi Vusi, Nkambule Bongani Brian, Diet-Induced Obesity Promotes the Upregulation of Fas Expression on T-cells, Biology, 10, 3, 2021. Crossref

  24. Kohn Martin, Lanfermann Christian, Laudeley Robert, Glage Silke, Rheinheimer Claudia, Klos Andreas, Complement and Chlamydia psittaci: Non-Myeloid-Derived C3 Predominantly Induces Protective Adaptive Immune Responses in Mouse Lung Infection, Frontiers in Immunology, 12, 2021. Crossref

  25. Adamski Łukasz Jan, Starzyńska Anna, Adamska Paulina, Kunc Michał, Sakowicz-Burkiewicz Monika, Marvaso Giulia, Alterio Daniela, Korwat Aleksandra, Jereczek-Fossa Barbara Alicja, Pęksa Rafał, High PD-L1 Expression on Tumor Cells Indicates Worse Overall Survival in Advanced Oral Squamous Cell Carcinomas of the Tongue and the Floor of the Mouth but Not in Other Oral Compartments, Biomedicines, 9, 9, 2021. Crossref

  26. Xu Suzanne, Foss Francine, New nonchemotherapy treatment options for cutaneous T-cell lymphomas, Expert Review of Anticancer Therapy, 21, 9, 2021. Crossref

  27. Salminen Antero, Immunosuppressive network promotes immunosenescence associated with aging and chronic inflammatory conditions, Journal of Molecular Medicine, 99, 11, 2021. Crossref

  28. Nigro Olga, Ferrari Andrea, Casanova Michela, Orbach Daniel, Leruste Amaury, Gatz Susanne A., Frappaz Didier, Massimino Maura, Controversies on the possible role of immune checkpoint inhibitors in pediatric cancers: balancing irAEs and efficacy, Tumori Journal, 107, 4, 2021. Crossref

  29. Willsmore Zena N., Coumbe Ben G. T., Crescioli Silvia, Reci Sara, Gupta Ayushi, Harris Robert J., Chenoweth Alicia, Chauhan Jitesh, Bax Heather J., McCraw Alexa, Cheung Anthony, Osborn Gabriel, Hoffmann Ricarda M., Nakamura Mano, Laddach Roman, Geh Jenny L. C., MacKenzie‐Ross Alastair, Healy Ciaran, Tsoka Sophia, Spicer James F., Josephs Debra H., Papa Sophie, Lacy Katie E., Karagiannis Sophia N., Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action, European Journal of Immunology, 51, 3, 2021. Crossref

  30. Kanev Kristiyan, Roelli Patrick, Wu Ming, Wurmser Christine, Delorenzi Mauro, Pfaffl Michael W., Zehn Dietmar, Tailoring the resolution of single-cell RNA sequencing for primary cytotoxic T cells, Nature Communications, 12, 1, 2021. Crossref

  31. Chen Chen, Liu Yanlong, Cui Binbin, Effect of radiotherapy on T cell and PD-1 / PD-L1 blocking therapy in tumor microenvironment, Human Vaccines & Immunotherapeutics, 17, 6, 2021. Crossref

  32. Ota Takayo, Fukui Tomoya, Nakahara Yoshiro, Takeda Takayuki, Uchino Junji, Mouri Takako, Kudo Keita, Nakajima Saki, Suzumura Tomohiro, Fukuoka Masahiro, Serum immune modulators during the first cycle of anti‐PD‐1 antibody therapy in non‐small cell lung cancer: Perforin as a biomarker, Thoracic Cancer, 11, 11, 2020. Crossref

  33. Wang Min, Zhu Jie, Zhao Fang, Xiao Jiani, Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Antitumor Immunosuppression of EGFR Wild Type Lung Cancers With Low PD-L1 Expression, Frontiers in Oncology, 11, 2021. Crossref

  34. Ponce Luis F., García‐Martínez Karina, León Kalet, Valiente Pedro A., Exploring the conformational dynamics of PD1 in complex with different ligands: What we can learn for designing novel PD1 signaling blockers? , Proteins: Structure, Function, and Bioinformatics, 89, 2, 2021. Crossref

  35. Habib Samar, El Andaloussi Abdeljabar, Elmasry Khaled, Handoussa Aya, Azab Manar, Elsawey Aliaa, Al-Hendy Ayman, Ismail Nahed, Appleton Judith A., PDL-1 Blockade Prevents T Cell Exhaustion, Inhibits Autophagy, and Promotes Clearance of Leishmania donovani, Infection and Immunity, 86, 6, 2018. Crossref

  36. Mor Adam, Strazza Marianne, Bridging the Gap: Connecting the Mechanisms of Immune-Related Adverse Events and Autoimmunity Through PD-1, Frontiers in Cell and Developmental Biology, 9, 2022. Crossref

  37. Li Si, Siriwon Natnaree, Zhang Xiaoyang, Yang Shuai, Jin Tao, He Feng, Kim Yu Jeong, Mac John, Lu Zhengfei, Wang Sijie, Han Xiaolu, Wang Pin, Enhanced Cancer Immunotherapy by Chimeric Antigen Receptor–Modified T Cells Engineered to Secrete Checkpoint Inhibitors, Clinical Cancer Research, 23, 22, 2017. Crossref

  38. Ponce Luis F., Leon Kalet, Valiente Pedro A., Unraveling a Conserved Conformation of the FG Loop upon the Binding of Natural Ligands to the Human and Murine PD1, The Journal of Physical Chemistry B, 126, 7, 2022. Crossref

  39. Spunde Karina, Korotkaja Ksenija, Zajakina Anna, Recombinant Viral Vectors for Therapeutic Programming of Tumour Microenvironment: Advantages and Limitations, Biomedicines, 10, 9, 2022. Crossref

  40. Nakamura Kenta, Okuyama Ryuhei, Changes in the Immune Cell Repertoire for the Treatment of Malignant Melanoma, International Journal of Molecular Sciences, 23, 21, 2022. Crossref

  41. Greenberg Jacques, Limberg Jessica, Verma Akanksha, Kim David, Chen Xiang, Lee Yeon J., Moore Maureen D., Ullmann Timothy M., Thiesmeyer Jessica W., Loewenstein Zachary, Chen Kevin J., Egan Caitlin E., Stefanova Dessislava, Bareja Rohan, Zarnegar Rasa, Finnerty Brendan M., Scognamiglio Theresa, Du Yi-Chieh Nancy, Elemento Olivier, Fahey Thomas J., Min Irene M., Metastatic pancreatic neuroendocrine tumors feature elevated T cell infiltration, JCI Insight, 7, 23, 2022. Crossref

Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain